135 related articles for article (PubMed ID: 2481546)
1. Inactivation of viruses and safety of stable plasma products.
Morgenthaler JJ
Beitr Infusionsther; 1989; 24():33-9. PubMed ID: 2481546
[TBL] [Abstract][Full Text] [Related]
2. [Virus safety of labile plasma products from the German viewpoint].
Stephan W
Beitr Infusionsther; 1989; 24():40-5. PubMed ID: 2481547
[TBL] [Abstract][Full Text] [Related]
3. [HIV safety of commercially produced human plasma proteins].
Hilfenhaus J
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():84-8. PubMed ID: 8000262
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of AIDS-causing retroviruses by the manufacturing procedures for human plasma proteins.
Hilfenhaus J; Gregersen JP
Behring Inst Mitt; 1988 Apr; (82):82-93. PubMed ID: 3044347
[TBL] [Abstract][Full Text] [Related]
6. Specific inactivation of viruses which can potentially contaminate blood products.
Horowitz B
Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
[TBL] [Abstract][Full Text] [Related]
7. Viral safety of a new highly purified factor VIII (OCTATE).
Biesert L; Lemon S; Goudeau A; Suhartono H; Wang L; Brede HD
J Med Virol; 1996 Apr; 48(4):360-6. PubMed ID: 8699169
[TBL] [Abstract][Full Text] [Related]
8. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
Meili EO
Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
Mannucci PM
Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
[TBL] [Abstract][Full Text] [Related]
10. [Virus safety of fresh frozen plasma].
Sugg U
Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549
[TBL] [Abstract][Full Text] [Related]
11. Current safety of clotting factor concentrates.
Epstein JS; Fricke WA
Arch Pathol Lab Med; 1990 Mar; 114(3):335-40. PubMed ID: 2407224
[TBL] [Abstract][Full Text] [Related]
12. Partitioning and inactivation of viruses during isolation of albumin and immunoglobulins by cold ethanol fractionation.
Morgenthaler JJ; Omar A
Dev Biol Stand; 1993; 81():185-90. PubMed ID: 8174802
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
Mauler R; Merkle W; Hilfenhaus J
Dev Biol Stand; 1987; 67():337-51. PubMed ID: 3111911
[TBL] [Abstract][Full Text] [Related]
14. Viral safety of plasma-derived factor VIII and IX concentrates.
Ludlam CA
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S19-23. PubMed ID: 9351532
[TBL] [Abstract][Full Text] [Related]
15. Viral safety of solvent-detergent treated blood products.
Horowitz B; Prince AM; Horowitz MS; Watklevicz C
Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
[TBL] [Abstract][Full Text] [Related]
16. H5N1 influenza virus and the safety of plasma products.
Kreil TR; Unger U; Orth SM; Petutschnig G; Kistner O; Poelsler G; Berting A
Transfusion; 2007 Mar; 47(3):452-9. PubMed ID: 17319825
[TBL] [Abstract][Full Text] [Related]
17. Pasteurized, monoclonal antibody factor VIII concentrate: establishing a new standard for purity and viral safety of plasma-derived concentrates.
Goldsmith JC
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):203-15. PubMed ID: 10759015
[TBL] [Abstract][Full Text] [Related]
18. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Transfusion; 2006 Dec; 46(12):2100-8. PubMed ID: 17176321
[TBL] [Abstract][Full Text] [Related]
19. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
[TBL] [Abstract][Full Text] [Related]
20. [Concentrate of coagulation factor IX: viral validation of the thermoinactivation process].
Zahorska R; Buchowicz I; Ejduk A
Acta Haematol Pol; 1995; 26(4):421-4. PubMed ID: 8571744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
